Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 13(1): 22367, 2023 12 15.
Article in English | MEDLINE | ID: mdl-38102196

ABSTRACT

Characterization of the pathophysiology of ARDS following chlorine gas inhalation in clinically relevant translational large animal models is essential, as the opportunity for clinical trials in this type of trauma is extremely limited. To investigate Cl2 concentration and gender-dependent ARDS severity. Sheep (n = 54) were exposed to air or Cl2 premixed in air at a concentration of 50, 100, 200, and 300 ppm for 30 min under anesthesia/analgesia and monitored for an additional 48 h in a conscious state. Cardiopulmonary variables and survival endpoints were compared between male and female sheep. Overall there were no significant differences in the responses of female and male sheep except pulmonary oxygenation tended to be better in the male sheep (300 ppm group), and the pulmonary arterial pressure was lower (200 ppm group). The onset of mild ARDS (200 < PaO2/FiO2 ≤ 300) was observed at 36 h post exposure in the 50 ppm group, whereas the 100 ppm group developed mild and moderate (100 ≤ PaO2/FiO2 ≤ 200) ARDS by 12 and 36 h after injury, respectively. The 200 ppm and 300 ppm groups developed moderate ARDS within 6 and 3 h after injury, respectively. The 300 ppm group progressed to severe (PaO2/FiO2 ≤ 100) ARDS at 18 h after injury. Increases in pPeak and pPlateau were noted in all injured animals. Compared to sham, inhalation of 200 ppm and 300 ppm Cl2 significantly increased lung extravascular water content. The thoracic cavity fluid accumulation dose-dependently increased with the severity of trauma as compared to sham. At necropsy, the lungs were red, heavy, solidified, and fluid filled; the injury severity grew with increasing Cl2 concentration. The severity of ARDS and mortality rate directly correlated to inhaled Cl2 concentrations. No significant sex-dependent differences were found in measured endpoint variables.


Subject(s)
Chlorine , Respiratory Distress Syndrome , Male , Female , Animals , Sheep , Chlorine/toxicity , Chlorine/therapeutic use , Lung , Administration, Inhalation
2.
PLoS One ; 16(4): e0250327, 2021.
Article in English | MEDLINE | ID: mdl-33930030

ABSTRACT

METHODS: Sepsis was induced by cotton smoke inhalation followed by intranasal administration of Pseudomonas aeruginosa in female (> 6 months) Balb/c and syndecan-1 knockout mice. Survival of mice, lung capillary endothelial glycocalyx integrity, lung water content, and vascular hyper-permeability were determined with or without HMW-SH treatment in these mice. Effects of HMW-SH on endothelial permeability and neutrophil migration were tested in in vitro setting. RESULTS: In septic wildtype mice, we found a severely damaged pulmonary microvascular endothelial glycocalyx and elevated levels of shed syndecan-1 in the circulation. These changes were associated with significantly increased pulmonary vascular permeability. In septic syndecan-1 knockout mice, extravascular lung water content was higher, and early death was observed. The administration of HMW-SH significantly reduced mortality and lung water content in septic syndecan-1 knockout mice, but not in septic wildtype mice. In in vitro setting, HMW-SH inhibited neutrophil migration and reduced cultured endothelial cell permeability increases. However, these effects were reversed by the addition of recombinant syndecan-1 ectodomain. CONCLUSIONS: HMW-SH reduced lung tissue damage and mortality in the absence of syndecan-1 protein, possibly by reducing vascular hyper-permeability and neutrophil migration. Our results further suggest that increased shed syndecan-1 protein levels are linked with the inefficiency of HMW-SH in septic wildtype mice.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Hyaluronic Acid/pharmacology , Neutrophils/drug effects , Pseudomonas Infections/drug therapy , Sepsis/drug therapy , Smoke Inhalation Injury/drug therapy , Syndecan-1/genetics , Animals , Capillary Permeability/drug effects , Cell Movement/drug effects , Disease Models, Animal , Endothelial Cells/drug effects , Endothelial Cells/immunology , Endothelial Cells/microbiology , Endothelium, Vascular/drug effects , Endothelium, Vascular/immunology , Endothelium, Vascular/microbiology , Female , Gene Deletion , Glycocalyx/immunology , Glycocalyx/metabolism , Lung/drug effects , Lung/immunology , Lung/microbiology , Mice , Mice, Inbred BALB C , Mice, Knockout , Neutrophils/immunology , Neutrophils/microbiology , Primary Cell Culture , Pseudomonas Infections/immunology , Pseudomonas Infections/microbiology , Pseudomonas Infections/mortality , Pseudomonas aeruginosa/growth & development , Pseudomonas aeruginosa/pathogenicity , Sepsis/immunology , Sepsis/microbiology , Sepsis/mortality , Smoke Inhalation Injury/immunology , Smoke Inhalation Injury/microbiology , Smoke Inhalation Injury/mortality , Survival Analysis , Syndecan-1/deficiency , Syndecan-1/immunology , Water/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...